Mass General Cancer Center physician-scientist Shawn Demehri, MD, PhD, has been elected to the American Society for Clinical Investigation (ASCI) as part of ASCI’s new class of members for 2022.
Dr. Demehri is the Director for the High Risk Skin Cancer Clinic, he is a board-certified dermatologist and a principal investigator at the Center for Cancer Immunology, and Cutaneous Biology Research Center at Massachusetts General Hospital. Dr. Demehri is a physician-scientist performing basic science and translational research in the area of cancer immunology related to melanoma and non-melanoma skin cancers.
For more information on this announcement or Dr. Demehri, please take a look at this original post on Massachusetts General Hospital’s news page.